Skip to main content
FAQs
Glossary
Close
FAQs
Why are some conditions more suitable for gene and cell therapies than others?
There is an approved treatment available for my condition - why can't I receive it?
How to look for approved medicines?
How are medicines developed and approved?
See all FAQs
Close
Glossary
Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Antibody
Antigen
Base editors
Cas9 nuclease
Chimeric Antigen Receptor (CAR)
Chromosome
Clinical trial
See full Glossary
EuroGCT
Menu
Close
Select language
English
Français
Deutsch
Italiano
Polski
Español
Português
Main navigation
Discover
Discover
Discover Gene and Cell Therapy
Educational Resources Directory
Educational Resources Directory
INTENS
INtestinal Tissue ENgineering Solution
LEARN
Listening to the experience of participants in neurosurgical trials
Discover Gene and Cell Therapy
Research Pathways
Research Pathways
Bringing new therapies from the lab to patients
EuroGCT Key Resources
EuroGCT Key Resources
ATMP Engage
Advanced Therapy Medicinal Products Patient and Public Involvement and Engagement Working Group
Actors and Network database
Actors and Network database
Bringing new therapies from the lab to patients
About Us
Our team and partners
Contact
Condition
Alzheimer's Disease
Blood disorders
Bowel Disease
Cancer
Cerebral Palsy
Cord Blood
Cystic Fibrosis
Diabetes
Epidermolysis Bullosa
Eye Disease
Heart Disease
Huntington's Disease
Immune Conditions
Kidney Disease
Liver Disease
Lung Disease
Motor Neurone Disease
Multiple Sclerosis
Muscle and Skeletal Diseases
Muscular Dystrophy
Neurological Disorders
Parkinson's Disease
Rare Diseases
Sickle Cell Disease
Skin
Spinal Cord Injuries
Spinal Muscular Atrophy
Stroke
Reproduction and Fertility
Theme
Blood Stem Cells
CAR-T Therapy
Cell and Gene Fundamentals
Cell Therapy
Clinical Trials
Cord Blood
Current and Potential Uses
Disease Modelling
Embryonic Stem Cells
Ethics and Society
Explore Stem Cells
Factsheets
Gene Editing
Gene Therapy
Industry
iPS cells
Methods and Tools
MSCs
Organoids
Patient Involvement
Policy & Regulation
Reprogramming
Research
Skin Stem Cells
Spotlight on Research
Stem Cell News
Tissue Engineering
Unproven Treatments
Search
Select language
English
Français
Deutsch
Italiano
Polski
Español
Português
Breadcrumb
Home
Resources
Resources
Search within the page or choose from the most common topics below
Theme
Stem Cell News
Current and Potential Uses
Research
Cell and Gene Fundamentals
Blood Stem Cells
CAR-T Therapy
Cell Therapy
iPS cells
Skin Stem Cells
Embryonic Stem Cells
MSCs
Clinical Trials
Patient Involvement
Cord Blood
Explore Stem Cells
Disease Modelling
Gene Editing
Tissue Engineering
Ethics and Society
Factsheets
Gene Therapy
Industry
Policy & Regulation
Unproven Treatments
Methods and Tools
Organoids
Reprogramming
Spotlight on Research
Condition
Stroke
Alzheimer's Disease
Spinal Muscular Atrophy
Eye Disease
Blood disorders
Bowel Disease
Cancer
Cerebral Palsy
Huntington's Disease
Motor Neurone Disease
Parkinson's Disease
Immune Conditions
Kidney Disease
Neurological Disorders
Lung Disease
Rare Diseases
Heart Disease
Muscle and Skeletal Diseases
Liver Disease
Cord Blood
Diabetes
Cystic Fibrosis
Muscular Dystrophy
Epidermolysis Bullosa
Multiple Sclerosis
Skin
Spinal Cord Injuries
Sickle Cell Disease
Reproduction and Fertility
Search by keyword
ECRIN CAMPUS for Regulatory and Ethical Requirements
ECRIN Rare Diseases Clinical Trials Toolbox
ECRIN Clinical Research Metadata Repository
Dish Life - The Game
Related Topics
Ethics and Society
Stem Cell News
EuroGCT Resource
Case Study: Early therapy classification considerations in developing skin equivalents
ISSCR Guidelines for Stem Cell Research and Clinical Translation
Manufacturing and analytics for lentivirus and AAV vectors: a visual and audio guide
World Health Organization (WHO) Resources
European Clinical Research Infrastructure Network (ECRIN) Resource
Key UK Resources
NIHR Clinical Trials Toolkit
ATMP Sweden: ATMP Clinical Study Guide
Taking ATMPs to Market
Viral vectors-what are the solutions to current scale up challenges?
The role of a Qualified Person (QP) within ATMPs
CGT Catapult: Cell Confluency Tool
Preparing for commercial GMP manufacture
RESTORE Project
New guidance on the development and marketing of ATMPs in the UK and EU in the post-BREXIT landscape
ARM Getting Ready for ATMPs in Europe
Pagination
First page
« First
Previous page
‹ Previous
…
Page
5
Page
6
Page
7
Page
8
Page
9
Page
10
Page
11
Page
12
Page
13
Next page
Next ›
Last page
Last »
Back to top
